CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer
2021 · Journal for ImmunoTherapy of Cancer · 219 citations
https://doi.org/10.1136/jitc-2020-001136
M
Moran Yang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
573
Citations
12
h-index
13
i10-index
Moran Yang is an academic researcher from Anhui Medical University. The author has contributed to research in topics: Immunotherapy and Immune Responses & Glycosylation and Glycoproteins Research & Gut microbiota and health. The author has an h-index of 12, co-authored 43 publications.
ORCID: 0000-0002-0601-9090Papers by this author
worksTumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer
2020 · British Journal of Cancer · 70 citations
https://doi.org/10.1038/s41416-020-1026-0
Targeting mesothelin-CD24 axis repolarizes tumor-associated macrophages to potentiate PD-1 blockade therapy in high-grade serous ovarian cancer
2025 · Journal for ImmunoTherapy of Cancer · 15 citations
https://doi.org/10.1136/jitc-2024-011230
Supplementary Data from Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027782
Data from Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.c.6711188.v3
Supplementary Data from Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027779.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat